Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interferon omega

Next Previous
X
Search
Drug Profile

Interferon omega

Alternative Names: IFN-omega; Interferon-omega; ITCA-638; Omega DUROS interferon therapy; Omega-interferon

Latest Information Update: 11 Aug 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Boehringer Ingelheim
  • Developer Boehringer Ingelheim; Intarcia Therapeutics
  • Class Antivirals; Interferons
  • Mechanism of Action Immunostimulants; Interferon type I stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Hepatitis C

Most Recent Events

  • 16 Apr 2007 Final results from a phase II clinical trial in patients with hepatitis C added to the adverse events and Viral Infections therapeutic trials sections
  • 10 Jun 2005 Data presented at the 18th International Conference on Antiviral Research (ICAR-2005) have been added to the Adverse Events and Viral Infections antimicrobial activity sections
  • 30 Nov 2004 Phase-II clinical trials in Hepatitis C in Russia (SC)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top